Trial intelligence / Profile preview

Metformin prior to hysterectomy in endometrial cancer

NCT01877564Phase 2Completed

Sponsor
University of Arkansas
Start
Aug 2013
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metformin in endometrial adenocarcinoma, sponsored by University of Arkansas. Started Aug 2013; status: completed.

02

Drugs

metformin
03

Conditions

endometrial adenocarcinoma

Beyond the preview

Go deeper on NCT01877564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01877564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call